
mRNA Development
and Manufacturing
GMP mRNA drug substance manufacturing from sequence to commercial-scale supply, built on a dedicated nucleic acid platform with integrated in-house pDNA template supply, LNP encapsulation, and a direct pathway to sterile fill-finish.
mRNA Manufacturing Platform
Our dedicated Grade C (ISO 7) cGMP environment, physically separated from protein manufacturing suites and purpose-built for mRNA and pDNA manufacturing at clinical and commercial scale.


mRNA Sequence Design and Optimization
We work with client-supplied sequences or support construct optimization for translational performance, stability, and regulatory suitability.
pDNA Template Supply
Linearized pDNA template manufactured in-house within the same Nucleic Acid Suite, removing inter-site transfer and comparability requirements from the earliest stage of the manufacturing chain.
In Vitro Transcription (IVT) and Capping
IVT process optimized for high mRNA yield and transcriptional fidelity. Our platform is capping technology agnostic, with cap structure selection based on your program requirements and IP strategy.
Downstream Purification
Multi-step purification incorporating DNase treatment, dsRNA removal, tangential flow filtration for concentration and buffer exchange, and sterile final filtration, validated for dsRNA impurity levels, residual DNA template clearance, and potency specifications.

mRNA Development
and Manufacturing
In vitro transcription optimized for mRNA yield, capping efficiency, and sequence fidelity.
RNA Modalities We Support
Self-Amplifying RNA (saRNA)
Enhanced expression formats delivering therapeutic effect at lower administered doses, expanding the potential of RNA-based medicines.
Non-Replicating mRNA
The established clinical format for vaccines, protein replacement therapies, and broader therapeutic applications, with a manufacturing platform designed for clinical and commercial scale.
Circular RNA (circRNA)
Stability-enhanced RNA format offering extended expression duration, supporting programs requiring prolonged protein production from a single administration.
Emerging RNA Formats
Support for emerging RNA therapeutic platforms, with our platform designed to adapt to novel formats as the field evolves.
Drug Substance Manufacturing Track Record
0+ years
of cGMP manufacturing experience
0
Critical Observations


3
BLA Submissions
0+
products manufactured

Ready to Start Your mRNA Program?
Every mRNA program starts with a conversation. Our team is ready to understand your requirements and find the right path forward.









